ProKidney (MEX:PROK) Current Accrued Expense : MXN135.56 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Current Accrued Expense?

ProKidney's Current Accrued Expense for the quarter that ended in Mar. 2024 was MXN135.56 Mil.

ProKidney's quarterly Current Accrued Expense declined from Sep. 2023 (MXN200.53 Mil) to Dec. 2023 (MXN172.20 Mil) and declined from Dec. 2023 (MXN172.20 Mil) to Mar. 2024 (MXN135.56 Mil).

ProKidney's annual Current Accrued Expense declined from Dec. 2021 (MXN151.41 Mil) to Dec. 2022 (MXN77.61 Mil) but then increased from Dec. 2022 (MXN77.61 Mil) to Dec. 2023 (MXN172.20 Mil).

ProKidney Current Accrued Expense Historical Data

The historical data trend for ProKidney's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Current Accrued Expense Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

67.85

151.41

77.61

172.20

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial									88.63	170.69	200.53	172.20	135.56

ProKidney Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

ProKidney Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of ProKidney's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney (MEX:PROK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.